Surveillance of efficacy and safety of drug PRITOR in patieNts with arterial hypertension, who do not tolerate ACE inhibitoR treatment

Inclusion Criteria:

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who do not tolerate ACE inhibitors (must be documented in the official ambulant documentation)

Inclusion criteria for the control arm (treated by ACEi):

• Patients over 18 years of age
• Arterial hypertension (SBP < 160 mmHg and DBP < 100 mmHg)
• Patients, who tolerate ACEi treatment

Exclusion Criteria:

• Cholestasis, severe hepatic insufficiency
• Allergy to telmisartan
• Gravidity or lactation

Exclusion criteria for the arm of patient treated by ACEi:

• Cholestasis, severe hepatic insufficiency
• Allergy to ACEi
• Gravidity or lactation

• Any patient with a diagnosis of arterial hypertension, who do not tolerated ACE inhibitor treatment treated by the drug PRITOR
• Exclusion criteria for the patients treated by the drug PRITOR must be read in conjunction with the local product information